<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Rizzo, Toni</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">Ouallet, Jean-Christophe</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">FACTSEP Results: L-carnitine Not Effective for Treatment of Fatigue in MS Patients</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2014</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2014-06-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">9-10</style></pages><abstract><style  face="normal" font="default" size="100%">Patients with multiple sclerosis (MS) commonly suffer from fatigue that negatively affects their functioning and quality of life. Both the cause and the consequences of MS fatigue are multidimensional and require multidisciplinary treatment for successful symptom management. This article presents the results of the Efficacy of L-carnitine Versus Placebo in the Treatment of Fatigue in Multiple Sclerosis study [FACTSEP; NCT01149525]</style></abstract><number><style face="normal" font="default" size="100%">29</style></number><volume><style face="normal" font="default" size="100%">14</style></volume></record></records></xml>